Wangdon Yoo

927 total citations
19 papers, 768 citations indexed

About

Wangdon Yoo is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Wangdon Yoo has authored 19 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Infectious Diseases and 10 papers in Hepatology. Recurrent topics in Wangdon Yoo's work include Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (10 papers) and HIV/AIDS drug development and treatment (6 papers). Wangdon Yoo is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (10 papers) and HIV/AIDS drug development and treatment (6 papers). Wangdon Yoo collaborates with scholars based in South Korea, United States and Ethiopia. Wangdon Yoo's co-authors include Soo‐Ok Kim, Sun Pyo Hong, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yoon‐Seon Lee, Yung Sang Lee, Dong Jin Suh and Hyun Jae Chung and has published in prestigious journals such as Gastroenterology, Hepatology and Nature Protocols.

In The Last Decade

Wangdon Yoo

18 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangdon Yoo South Korea 10 609 501 223 97 83 19 768
J Slusarczyk Poland 14 444 0.7× 285 0.6× 90 0.4× 38 0.4× 28 0.3× 71 622
Karen Cristiano Italy 11 538 0.9× 580 1.2× 169 0.8× 42 0.4× 106 1.3× 22 780
Shikha Shrivastava India 9 256 0.4× 117 0.2× 62 0.3× 44 0.5× 197 2.4× 26 462
Natàlia Casamitjana Spain 11 632 1.0× 293 0.6× 112 0.5× 51 0.5× 308 3.7× 18 868
Jose A. Garcia-Rivera United States 11 161 0.3× 185 0.4× 139 0.6× 178 1.8× 24 0.3× 18 426
A. V. Kachko Russia 12 213 0.3× 227 0.5× 100 0.4× 116 1.2× 51 0.6× 31 451
Naomi K. Boatright United States 6 210 0.3× 128 0.3× 202 0.9× 53 0.5× 10 0.1× 6 414
Christian O. Simon Germany 17 860 1.4× 71 0.1× 178 0.8× 91 0.9× 39 0.5× 31 1.1k
M. Duhamel Belgium 6 532 0.9× 574 1.1× 102 0.5× 72 0.7× 13 0.2× 8 743
Andreas R. Kammer Switzerland 12 346 0.6× 387 0.8× 94 0.4× 163 1.7× 76 0.9× 13 793

Countries citing papers authored by Wangdon Yoo

Since Specialization
Citations

This map shows the geographic impact of Wangdon Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangdon Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangdon Yoo more than expected).

Fields of papers citing papers by Wangdon Yoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangdon Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangdon Yoo. The network helps show where Wangdon Yoo may publish in the future.

Co-authorship network of co-authors of Wangdon Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Wangdon Yoo. A scholar is included among the top collaborators of Wangdon Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangdon Yoo. Wangdon Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ahn, Sang Hoon, Kwang‐Hyub Han, Soo‐Ok Kim, et al.. (2013). Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B. 19(4). 399–408. 1 indexed citations
2.
Michailidis, Eleftherios, Karen A. Kirby, Atsuko Hachiya, et al.. (2012). Antiviral therapies: Focus on hepatitis B reverse transcriptase. The International Journal of Biochemistry & Cell Biology. 44(7). 1060–1071. 38 indexed citations
3.
Jang, Jeong Won, et al.. (2011). Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Science. 103(2). 296–304. 36 indexed citations
4.
Michailidis, Eleftherios, Kamlendra Singh, Karen A. Kirby, et al.. (2011). Hepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spots.. PubMed. 2(4). 253–260. 3 indexed citations
5.
Jung, Young Kul, Jong Eun Yeon, Ji Hoon Kim, et al.. (2010). Virologic Response at 12 Months of Treatment Predicts Sustained Antiviral Efficacy in Patients with Adefovir-Treated Lamivudine-Resistant Chronic Hepatitis B. Gut and Liver. 4(2). 212–218. 3 indexed citations
6.
Hong, Sun Pyo, Eun Hee Lee, Eun Ok Kim, et al.. (2008). High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nature Protocols. 3(9). 1476–1484. 31 indexed citations
7.
8.
Yim, Hyung Joon, Kwan Soo Byun, Jong Eun Yeon, et al.. (2007). Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea. Digestive Diseases and Sciences. 52(9). 2403–2409. 6 indexed citations
9.
Lee, Eun Hee, Hyun Jae Chung, Heung Bum Oh, et al.. (2007). Human Papilloma Virus Genotyping Assay using Restriction Fragment Mass Polymorphism Analysis, and Its Comparison with Sequencing and Hybrid Capture Assays. Annals of Laboratory Medicine. 27(1). 62–68. 8 indexed citations
11.
Lee, Chang Hong, Soo‐Ok Kim, Kwan Soo Byun, et al.. (2006). Predominance of Hepatitis B Virus YMDD Mutants Is Prognostic of Viral DNA Breakthrough. Gastroenterology. 130(4). 1144–1152. 42 indexed citations
12.
Lee, Yoon‐Seon, Dong Jin Suh, Young‐Suk Lim, et al.. (2006). Increased risk of adefovir resistance in patients with lamivudine‐resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy†. Hepatology. 43(6). 1385–1391. 261 indexed citations
13.
Kim, Hyun Sook, Kwang‐Hyub Han, Sang Hoon Ahn, et al.. (2005). Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization. Antiviral Therapy. 10(3). 441–449. 69 indexed citations
14.
Kim, Yoon Jun, Soo‐Ok Kim, Hyun Jae Chung, et al.. (2005). Population Genotyping of Hepatitis C Virus by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis of Short DNA Fragments. Clinical Chemistry. 51(7). 1123–1131. 36 indexed citations
15.
Hong, Sun Pyo, Nam Keun Kim, Seong Gyu Hwang, et al.. (2004). Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. Journal of Hepatology. 40(5). 837–844. 116 indexed citations
16.
Hong, Sun Pyo, Wangdon Yoo, Robert Putnak, et al.. (2001). Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA14-14-2 Adapted to Vero Cells. DNA sequence. 12(5-6). 437–442. 5 indexed citations
17.
Srivastava, Ashok K., J. Robert Putnak, Sun Pyo Hong, et al.. (2001). A purified inactivated Japanese encephalitis virus vaccine made in vero cells. Vaccine. 19(31). 4557–4565. 79 indexed citations
18.
Hong, Sun Pyo, Wangdon Yoo, Robert Putnak, et al.. (2001). Preparation of a purified, inactivated Japanese encephalitis (JE) virus vaccine in Vero cells. Biotechnology Letters. 23(19). 1565–1573. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026